Ontology type: schema:ScholarlyArticle Open Access: True
2014-02
AUTHORSC P Fox, D Burns, A N Parker, K S Peggs, C M Harvey, S Natarajan, D I Marks, B Jackson, G Chakupurakal, M Dennis, Z Lim, G Cook, B Carpenter, A R Pettitt, S Mathew, L Connelly-Smith, J A L Yin, M Viskaduraki, R Chakraverty, K Orchard, B E Shaw, J L Byrne, C Brookes, C F Craddock, S Chaganti
ABSTRACTEBV-associated post-transplant lymphoproliferative disease (PTLD) following Alemtuzumab-based allo-SCT is a relatively uncommon and challenging clinical problem but has not received detailed study in a large cohort. Quantitative-PCR (qPCR) monitoring for EBV reactivation post allo-SCT is now commonplace but its diagnostic and predictive value remains unclear. Sixty-nine patients with PTLD following Alemtuzumab-based allo-SCT were studied. Marked clinicopathological heterogeneity was evident; lymphadenopathy was frequently absent, whereas advanced extranodal disease was common. The median viral load at clinical presentation was 49 300 copies/mL (50-65 200 000 copies/mL) and, notably, 23% and 45% of cases, respectively, had 10 000 and 40 000 copies/mL. The overall response rate to rituximab as first-line therapy was 70%. For rituximab failures, chemotherapy was ineffectual but DLIs were successful. A four-parameter prognostic index predicted response to therapy (OR 0.30 (0.12-0.74); P=0.009] and PTLD mortality (hazard ratio (HR) 1.81 (1.12-2.93) P=0.02) on multivariate analysis. This is the largest detailed series of EBV-associated PTLD after allo-SCT. At clinical presentation, EBV-qPCR values are frequently below customary thresholds for pre-emptive therapy, challenging current paradigms for monitoring and intervention. A four-point score identifies a proportion of patients at risk of rituximab-refractory disease for whom alternative therapy is needed. More... »
PAGES280
http://scigraph.springernature.com/pub.10.1038/bmt.2013.170
DOIhttp://dx.doi.org/10.1038/bmt.2013.170
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1042845189
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/24212561
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antibodies, Monoclonal, Murine-Derived",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Agents",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cohort Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Epstein-Barr Virus Infections",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Hematopoietic Stem Cell Transplantation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Immunotherapy",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Lymphoproliferative Disorders",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Prognosis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Retrospective Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Rituximab",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Survival Analysis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Transplantation Conditioning",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Viral Load",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Nottingham University Hospitals NHS Trust",
"id": "https://www.grid.ac/institutes/grid.240404.6",
"name": [
"1] Department of Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK [2] School of Cancer Sciences, University of Birmingham, Birmingham, UK."
],
"type": "Organization"
},
"familyName": "Fox",
"givenName": "C P",
"id": "sg:person.0671674457.17",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671674457.17"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Birmingham",
"id": "https://www.grid.ac/institutes/grid.6572.6",
"name": [
"1] School of Cancer Sciences, University of Birmingham, Birmingham, UK [2] University Hospitals Birmingham NHS Trust, Birmingham, UK."
],
"type": "Organization"
},
"familyName": "Burns",
"givenName": "D",
"id": "sg:person.0776216256.96",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0776216256.96"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Beatson West of Scotland Cancer Centre",
"id": "https://www.grid.ac/institutes/grid.422301.6",
"name": [
"The Beatson, West of Scotland Cancer Centre, Glasgow, UK."
],
"type": "Organization"
},
"familyName": "Parker",
"givenName": "A N",
"id": "sg:person.012517505242.47",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012517505242.47"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University College London",
"id": "https://www.grid.ac/institutes/grid.83440.3b",
"name": [
"University College London, Cancer Institute, London, UK."
],
"type": "Organization"
},
"familyName": "Peggs",
"givenName": "K S",
"id": "sg:person.0630024242.03",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630024242.03"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Nottingham University Hospitals NHS Trust",
"id": "https://www.grid.ac/institutes/grid.240404.6",
"name": [
"Department of Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK."
],
"type": "Organization"
},
"familyName": "Harvey",
"givenName": "C M",
"id": "sg:person.01160560056.28",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160560056.28"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Manchester Royal Infirmary",
"id": "https://www.grid.ac/institutes/grid.419319.7",
"name": [
"Manchester Royal Infirmary, Manchester, UK."
],
"type": "Organization"
},
"familyName": "Natarajan",
"givenName": "S",
"type": "Person"
},
{
"affiliation": {
"alternateName": "University Hospitals Bristol NHS Foundation Trust",
"id": "https://www.grid.ac/institutes/grid.410421.2",
"name": [
"University Hospitals Bristol NHS Trust, Bristol, UK."
],
"type": "Organization"
},
"familyName": "Marks",
"givenName": "D I",
"id": "sg:person.01222003555.09",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222003555.09"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"The Royal Marsden, London, UK."
],
"type": "Organization"
},
"familyName": "Jackson",
"givenName": "B",
"type": "Person"
},
{
"affiliation": {
"alternateName": "University Hospitals Birmingham NHS Foundation Trust",
"id": "https://www.grid.ac/institutes/grid.412563.7",
"name": [
"University Hospitals Birmingham NHS Trust, Birmingham, UK."
],
"type": "Organization"
},
"familyName": "Chakupurakal",
"givenName": "G",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Christie Hospital NHS Foundation Trust",
"id": "https://www.grid.ac/institutes/grid.412917.8",
"name": [
"The Christie NHS Foundation Trust, Manchester, UK."
],
"type": "Organization"
},
"familyName": "Dennis",
"givenName": "M",
"id": "sg:person.0662740571.93",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0662740571.93"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "King's College Hospital NHS Foundation Trust",
"id": "https://www.grid.ac/institutes/grid.429705.d",
"name": [
"King's College Hospital NHS Trust, London, UK."
],
"type": "Organization"
},
"familyName": "Lim",
"givenName": "Z",
"id": "sg:person.0761762547.37",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761762547.37"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "St James's University Hospital",
"id": "https://www.grid.ac/institutes/grid.443984.6",
"name": [
"St James's Institute of Oncology, Leeds, UK."
],
"type": "Organization"
},
"familyName": "Cook",
"givenName": "G",
"id": "sg:person.07624006200.62",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07624006200.62"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Royal Free Hospital",
"id": "https://www.grid.ac/institutes/grid.426108.9",
"name": [
"Royal Free London NHS Trust, London, UK."
],
"type": "Organization"
},
"familyName": "Carpenter",
"givenName": "B",
"id": "sg:person.0625411274.95",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0625411274.95"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Liverpool",
"id": "https://www.grid.ac/institutes/grid.10025.36",
"name": [
"University of Liverpool, Liverpool, UK."
],
"type": "Organization"
},
"familyName": "Pettitt",
"givenName": "A R",
"id": "sg:person.016042767534.98",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016042767534.98"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Newcastle upon Tyne Hospitals NHS Foundation Trust",
"id": "https://www.grid.ac/institutes/grid.420004.2",
"name": [
"The Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK."
],
"type": "Organization"
},
"familyName": "Mathew",
"givenName": "S",
"type": "Person"
},
{
"affiliation": {
"alternateName": "University Hospitals of Leicester NHS Trust",
"id": "https://www.grid.ac/institutes/grid.269014.8",
"name": [
"University Hospitals of Leicester NHS Trust, Leicester, UK."
],
"type": "Organization"
},
"familyName": "Connelly-Smith",
"givenName": "L",
"id": "sg:person.0761574225.28",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761574225.28"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University College London",
"id": "https://www.grid.ac/institutes/grid.83440.3b",
"name": [
"University College London, Cancer Institute, London, UK."
],
"type": "Organization"
},
"familyName": "Yin",
"givenName": "J A L",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cancer Research UK Clinical Trials Unit",
"id": "https://www.grid.ac/institutes/grid.470294.c",
"name": [
"Cancer Research UK Clinical Trials Unit, University of Birmingham, UK."
],
"type": "Organization"
},
"familyName": "Viskaduraki",
"givenName": "M",
"id": "sg:person.01121251015.56",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121251015.56"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Royal Free Hospital",
"id": "https://www.grid.ac/institutes/grid.426108.9",
"name": [
"Royal Free London NHS Trust, London, UK."
],
"type": "Organization"
},
"familyName": "Chakraverty",
"givenName": "R",
"id": "sg:person.01043755643.50",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01043755643.50"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University Hospital Southampton NHS Foundation Trust",
"id": "https://www.grid.ac/institutes/grid.430506.4",
"name": [
"University Hospital Southampton NHS Trust, Southampton, UK."
],
"type": "Organization"
},
"familyName": "Orchard",
"givenName": "K",
"id": "sg:person.01172634460.05",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172634460.05"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"The Royal Marsden, London, UK."
],
"type": "Organization"
},
"familyName": "Shaw",
"givenName": "B E",
"id": "sg:person.0727054455.03",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727054455.03"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Nottingham University Hospitals NHS Trust",
"id": "https://www.grid.ac/institutes/grid.240404.6",
"name": [
"Department of Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK."
],
"type": "Organization"
},
"familyName": "Byrne",
"givenName": "J L",
"id": "sg:person.012720377652.37",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012720377652.37"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cancer Research UK Clinical Trials Unit",
"id": "https://www.grid.ac/institutes/grid.470294.c",
"name": [
"Cancer Research UK Clinical Trials Unit, University of Birmingham, UK."
],
"type": "Organization"
},
"familyName": "Brookes",
"givenName": "C",
"id": "sg:person.01124120120.23",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124120120.23"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Birmingham",
"id": "https://www.grid.ac/institutes/grid.6572.6",
"name": [
"1] School of Cancer Sciences, University of Birmingham, Birmingham, UK [2] University Hospitals Birmingham NHS Trust, Birmingham, UK."
],
"type": "Organization"
},
"familyName": "Craddock",
"givenName": "C F",
"id": "sg:person.0656121743.41",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656121743.41"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Birmingham",
"id": "https://www.grid.ac/institutes/grid.6572.6",
"name": [
"1] School of Cancer Sciences, University of Birmingham, Birmingham, UK [2] University Hospitals Birmingham NHS Trust, Birmingham, UK."
],
"type": "Organization"
},
"familyName": "Chaganti",
"givenName": "S",
"id": "sg:person.01312321477.66",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312321477.66"
],
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.1182/blood-2008-09-178046",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1001363434"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2009-08-239186",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1008268162"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1365-2141.2011.08855.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1009646566"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1365-2141.2011.08855.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1009646566"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1080/146532401317070899",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1014122252"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood.v102.3.839",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1014127975"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1080/146532401753173981",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1015662038"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2003-12-4287",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1018818994"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1399-3062.2009.00411.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024847734"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.bmt.1703893",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028634409",
"https://doi.org/10.1038/sj.bmt.1703893"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2010-04-281873",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1029198015"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bmt.2008.386",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032016402",
"https://doi.org/10.1038/bmt.2008.386"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.bmt.1701554",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032062237",
"https://doi.org/10.1038/sj.bmt.1701554"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.bmt.1701554",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032062237",
"https://doi.org/10.1038/sj.bmt.1701554"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejm199409083311017",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033227626"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2002-10-3001",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033390432"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/tp.0b013e31819f1c49",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034858632"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/tp.0b013e31819f1c49",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034858632"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/tp.0b013e31819f1c49",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034858632"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1399-3062.2009.00410.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1035294234"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.trim.2011.03.002",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037505438"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/tp.0b013e3181e7a3bf",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1039221212"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/tp.0b013e3181e7a3bf",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1039221212"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/tp.0b013e3181e7a3bf",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1039221212"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.bbmt.2010.10.003",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040998307"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood.v99.12.4364",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1047135013"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2011-08-371971",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050222671"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejm199404283301703",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052696593"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bmt.2008.149",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1053401780",
"https://doi.org/10.1038/bmt.2008.149"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.1999.17.4.1244",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1074549729"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1074702400",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1079419676",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1081659928",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1082659219",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1083238846",
"type": "CreativeWork"
}
],
"datePublished": "2014-02",
"datePublishedReg": "2014-02-01",
"description": "EBV-associated post-transplant lymphoproliferative disease (PTLD) following Alemtuzumab-based allo-SCT is a relatively uncommon and challenging clinical problem but has not received detailed study in a large cohort. Quantitative-PCR (qPCR) monitoring for EBV reactivation post allo-SCT is now commonplace but its diagnostic and predictive value remains unclear. Sixty-nine patients with PTLD following Alemtuzumab-based allo-SCT were studied. Marked clinicopathological heterogeneity was evident; lymphadenopathy was frequently absent, whereas advanced extranodal disease was common. The median viral load at clinical presentation was 49\u2009300 copies/mL (50-65\u2009200\u2009000 copies/mL) and, notably, 23% and 45% of cases, respectively, had \ue2fa10\u2009000 and \ue2fa40\u2009000 copies/mL. The overall response rate to rituximab as first-line therapy was 70%. For rituximab failures, chemotherapy was ineffectual but DLIs were successful. A four-parameter prognostic index predicted response to therapy (OR 0.30 (0.12-0.74); P=0.009] and PTLD mortality (hazard ratio (HR) 1.81 (1.12-2.93) P=0.02) on multivariate analysis. This is the largest detailed series of EBV-associated PTLD after allo-SCT. At clinical presentation, EBV-qPCR values are frequently below customary thresholds for pre-emptive therapy, challenging current paradigms for monitoring and intervention. A four-point score identifies a proportion of patients at risk of rituximab-refractory disease for whom alternative therapy is needed. ",
"genre": "research_article",
"id": "sg:pub.10.1038/bmt.2013.170",
"inLanguage": [
"en"
],
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1096890",
"issn": [
"0268-3369",
"1476-5365"
],
"name": "Bone Marrow Transplantation",
"type": "Periodical"
},
{
"issueNumber": "2",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "49"
}
],
"name": "EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era",
"pagination": "280",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"cc16f524fa364f3333a9c3b937507fec83d4ed6ebf25764a51971f84798d4b83"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"24212561"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"8702459"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1038/bmt.2013.170"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1042845189"
]
}
],
"sameAs": [
"https://doi.org/10.1038/bmt.2013.170",
"https://app.dimensions.ai/details/publication/pub.1042845189"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-10T18:58",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000436.jsonl",
"type": "ScholarlyArticle",
"url": "https://www.nature.com/articles/bmt2013170"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bmt.2013.170'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bmt.2013.170'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bmt.2013.170'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bmt.2013.170'
This table displays all metadata directly associated to this object as RDF triples.
440 TRIPLES
21 PREDICATES
76 URIs
39 LITERALS
27 BLANK NODES